Stock listing
Bioversys Ag
Selected listing: W33 · FWB · EUR · DE
Bioversys Ag (Frankfurt:W33), Health Technology. Latest release Sep 9, 2026: BioVersys reports half-year 2026 results: BV100 pivotal RIV-TARGET trial actively…
- Ticker
- Frankfurt:W33
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Bioversys Ag
BioVersys reports half-year 2026 results: BV100 pivotal RIV-TARGET trial actively recruiting, alpibectir Phase 2b/c underway, operations funded into 2028
September 9, 2026
BioVersys to Present at H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
BioVersys granted Fast-Track Designation from US FDA for BV100
September 2, 2026
BioVersys to report its half-year 2026 financial results, provide a business update and host a conference call
August 26, 2026
BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders
April 30, 2026